Works matching IS 01926233 AND DT 2024 AND VI 52 AND IP 2/3

Results: 5
    1

    Complex In Vitro Model Characterization for Context of Use in Toxicologic Pathology: Use Cases by Collaborative Teams of Biologists, Bioengineers, and Pathologists.

    Published in:
    Toxicologic Pathology, 2024, v. 52, n. 2/3, p. 123, doi. 10.1177/01926233241253811
    By:
    • Stokar-Regenscheit, Nadine;
    • Bell, Luisa;
    • Berridge, Brian;
    • Rudmann, Daniel;
    • Tagle, Danilo;
    • Hargrove-Grimes, Passley;
    • Schaudien, Dirk;
    • Hahn, Kerstin;
    • Kühnlenz, Julia;
    • Ashton, Randolph S.;
    • Tseng, Min;
    • Reichelt, Mike;
    • Laing, Steven T.;
    • Kiyota, Tomomi;
    • Chamanza, Ronnie;
    • Sura, Radhakrishna;
    • Tomlinson, Lindsay
    Publication type:
    Article
    2
    3
    4
    5

    Scientific and Regulatory Policy Committee Points to Consider: Review of the United States Food and Drug Administration (FDA) Guidance on Pathology Peer Review in Nonclinical Toxicology Studies.

    Published in:
    Toxicologic Pathology, 2024, v. 52, n. 2/3, p. 138, doi. 10.1177/01926233241248654
    By:
    • McDorman, Kevin S.;
    • Bennet, Bindu M.;
    • Colman, Karyn;
    • Fikes, James D.;
    • Keirstead, Natalie D.;
    • Lanning, Lynda;
    • Munch, Barbara;
    • Romeike, Annette;
    • Schafer, Kenneth A.;
    • Schorsch, Frédéric;
    • Thibodeau, Michael S.;
    • Thomas, Heath C.;
    • Troth, Sean;
    • Vahle, John L.;
    • Geoly, Frank J.
    Publication type:
    Article